CLINICAL_TRIALS
trial_result
· 2011-03-08
Clinical Trial Update: Trial of Etoricoxib (Arcoxia) Taken Prophylactically to Prevent Ramadan Headache [Phase 4]
Summary
A Phase 4 study evaluated whether prophylactic etoricoxib (Arcoxia) can prevent Ramadan-associated headaches; the trial has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hartford Hospital | Conditions: Headache, Fasting | Phase 4 | Status: COMPLETED